-
Value of Liquid Biopsy for Genomic Profiling in Non-Small Cell Lung Cancer in France: A Pharmacoeconomic Model
Mar 10, 2025, 14:00 PM -
Efficacy of Improvisational Communication Training for Health Workers in Emergency Care Unit in Hungary: Quazy Experimental Study
Mar 10, 2025, 14:00 PM -
Estimating Lung Cancer Screening Utilization in the US Using the 2023 Behavioral Risk Factor Surveillance System Data
Mar 10, 2025, 14:00 PM -
No Claim Left Behind: Viability of Assessing Early Real-World Vaccine Effectiveness in Open and Closed Administrative Healthcare Claims
Mar 10, 2025, 14:00 PM -
EHR Trends in First-Time ADHD Diagnoses and Amphetamine Prescriptions Across Age Groups (2021-2024)
Mar 10, 2025, 14:00 PM -
Survival Outcomes of Chemotherapy and Radiotherapy among Non-Small Cell Lung Cancer Patients with Brain Metastases: A SEER-based Cohort Analysis
Mar 10, 2025, 14:00 PM -
Impact of Social Determinants of Health on Severe Maternal Morbidity and Pregnancy Outcomes
Mar 10, 2025, 14:00 PM -
The Economic Burden of Illness for Patients with Idiopathic Pulmonary Fibrosis Utilizing Treatment Cohorts: A US Retrospective Claims Study
Mar 10, 2025, 14:00 PM -
Do Existing Caregiver Assessments Measure What's Important to Caregivers?
Mar 10, 2025, 14:00 PM -
Is There Value in Knowing? Perspectives of Cancer Screening Outcomes Among the US General Population
Mar 10, 2025, 14:00 PM -
Exploring the Impact of Serum Phosphate Levels and Hyperphosphatemia on Renal Outcomes: A Real-World Evidence Study
Mar 10, 2025, 14:00 PM -
Systematic Literature Review and Network Meta-Analysis of Crovalimab Compared With Eculizumab, Ravulizumab and Best Supportive Care in Paroxysmal Nocturnal Hemoglobinuria
Mar 10, 2025, 14:00 PM -
Trends in Use of Cost-Minimization Analyses in CDA-AMC Reimbursement Submissions
Mar 10, 2025, 14:00 PM -
Cost-Utility Analysis and Value-Based Pricing of Digital Therapeutics for Pulmonary Rehabilitation in Patients With Chronic Respiratory Disease: A Multicenter Randomized Controlled Trial
Mar 10, 2025, 14:00 PM -
Public Health Impact and Cost-Effectiveness of Adjuvanted RSVPreF3 Vaccination in US Adults Aged 60 Years with Cardiopulmonary Disease
Mar 10, 2025, 14:00 PM -
National and State Population-Level Estimated Economic Impact of Ocrelizumab on Cumulative Disabilities Avoided and Work Productivity Under Different Access Scenarios in the United States
Mar 10, 2025, 14:00 PM -
Comparison of AI-Enhanced Tools for Automating Scientific Literature Reviews
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization for Medicare Patients with Non-Cystic Fibrosis Bronchiectasis (NCFB) and Exacerbations Coinfected with Pseudomonas aeruginosa
Mar 10, 2025, 14:00 PM -
Association of Systemic Lupus Erythematosus and Psychosocial Outcomes: Analysis of a Nationally Representative Data, 2017-2022
Mar 10, 2025, 14:00 PM -
Approaches to Decreasing Emotional Burden during Qualitative Interviews to Improve Data Quality and Participant Engagement
Mar 10, 2025, 14:00 PM
